Brennan J M, O'Dwyer P J, Ozols R F, LaCreta F P
Department of Medical Oncology, Fox Chase Cancer Center, Philadelphia, PA 19111.
J Chromatogr. 1993 Oct 22;620(1):121-8. doi: 10.1016/0378-4347(93)80059-d.
A sensitive and reproducible HPLC procedure was developed for the simultaneous determination of the diastereoisomers of the synthetic amino acid L-buthionine-(SR)-sulfoximine (BSO) in human plasma and urine. Plasma samples were prepared for analysis by addition of internal standard (L-norleucine) followed by ultrafiltration using disposable centrifugal filtration units. Urine samples received internal standard followed by solid phase extraction using disposable C18 cartridges. All samples were derivatized with phenylisothiocyanate (PITC). The derivatized amino acids were separated by HPLC on an octyldecyl column (250 mm x 4.6 mm I.D., 5 microns particle size) using a mobile phase of sodium acetate-acetonitrile-triethylamine-ethylaminediaminetetraacetic acid. The column effluent was monitored at 254 nm and quantitation was performed using peak areas. The linear range for each diastereoisomer of L-(SR)-BSO was from 2 to 100 micrograms/ml in plasma and from 10 to 1000 micrograms/ml in urine. The method is reproducible, convenient and sensitive, illustrating its utility for application in pharmacokinetic studies.
建立了一种灵敏且可重现的高效液相色谱法,用于同时测定人血浆和尿液中合成氨基酸L-丁硫氨酸-(SR)-亚砜亚胺(BSO)的非对映异构体。血浆样品通过加入内标(L-正亮氨酸)进行分析前处理,随后使用一次性离心过滤装置进行超滤。尿液样品加入内标后,使用一次性C18柱进行固相萃取。所有样品均用异硫氰酸苯酯(PITC)衍生化。衍生化的氨基酸在十八烷基柱(250 mm×4.6 mm内径,5微米粒径)上通过高效液相色谱分离,流动相为醋酸钠-乙腈-三乙胺-乙二胺四乙酸。在254 nm处监测柱流出物,并使用峰面积进行定量。L-(SR)-BSO的每种非对映异构体在血浆中的线性范围为2至100微克/毫升,在尿液中的线性范围为10至1000微克/毫升。该方法可重现、方便且灵敏,表明其在药代动力学研究中的应用价值。